Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis. [electronic resource]
Producer: 20041222Description: 986-90 p. digitalISSN:- 0340-6245
- Coronary Artery Disease -- drug therapy
- Disease Progression
- Drug Resistance -- genetics
- Genotype
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Lipopolysaccharide Receptors -- genetics
- Middle Aged
- Pharmacogenetics
- Polymorphism, Single Nucleotide -- physiology
- Pravastatin -- pharmacology
- Promoter Regions, Genetic -- genetics
- Receptors, Immunologic -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.